NDC 49288-0322

Red Maple

Red Maple

Red Maple is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Acer Rubrum Pollen.

Product ID	49288-0322_13c9eea1-38b5-472b-b735-a814ca886718
NDC	49288-0322
Product Type	Human Prescription Drug
Proprietary Name	Red Maple
Generic Name	Red Maple
Dosage Form	Injection, Solution
Route of Administration	INTRADERMAL; SUBCUTANEOUS
Marketing Start Date	1974-03-23
Marketing Category	BLA / BLA
Application Number	BLA102223
Labeler Name	Antigen Laboratories, Inc.
Substance Name	ACER RUBRUM POLLEN
Active Ingredient Strength	0 g/mL
Pharm Classes	Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC]
NDC Exclude Flag	E
Listing Certified Through	2017-12-31

Packaging

NDC 49288-0322-4

30 mL in 1 VIAL, MULTI-DOSE (49288-0322-4)

Marketing Start Date	1974-03-23
NDC Exclude Flag	N
Sample Package?	N

NDC SPL Data Element Entries

NDC 49288-0322-4 [49288032204]

Red Maple INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1974-03-23
Inactivation Date	2019-10-21

NDC 49288-0322-2 [49288032202]

Red Maple INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1974-03-23
Inactivation Date	2019-10-21

NDC 49288-0322-3 [49288032203]

Red Maple INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1974-03-23
Inactivation Date	2019-10-21

NDC 49288-0322-5 [49288032205]

Red Maple INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1974-03-23
Inactivation Date	2019-10-21

NDC 49288-0322-1 [49288032201]

Red Maple INJECTION, SOLUTION

Marketing Category	BLA
Application Number	BLA102223
Product Type	HUMAN PRESCRIPTION DRUG
Marketing Start Date	1974-03-23
Inactivation Date	2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ACER RUBRUM POLLEN	.05 g/mL

OpenFDA Data

SPL SET ID:	3be2afc4-b2dc-4b0f-b314-5ade25922b66
Manufacturer	Antigen Laboratories, Inc.
UNII	E03U1K03LK QQ00BED0DV 43R41XZ627 KPO1Z9N98A 68R9X9Y96X LJT6I6Z8FD 68P4F4M6VD 17Q05812N1 34X886W1H4 P6K070AR8V NX974IRT8E ER172J09FM KV6DYF25M4 Z4Y9ZSV4KK 2A64U81OQ3 O99P60FU6G OZJ4OE173N W34X0P8636 3538FNV8AY CU781COT7M 43IR7KR479 Y3FRX92Z0E 59WAV8G5X5 928OC2TJDA 434DQ2U4JX R9JBC6687X E4CG5Q55M1 3R393IX840 95447163DG 2147EPR64I 6M2JIH93ZN G684LX721Q 0MGE63QPFJ 1L67OBT731 VU8C8SB23P BWC8DYU8OS 5Q246DS5BS 030R993R8E 59070I8M63 96LRW14765 S8A4X05W7J 6EIJ3D04MR ARW43087I1 FB7IP650ET 51I6N3XIML ZGS382Y3AV V38QUQ7861 476DVV63WP 23H70FYJ5U 9UC4BM3IZ0 3I9T68187H G2A764T54B G82398SD3I TX1ER5UV3T 15L060HV8H 7JWJ3HXZ9U 232DMH0XVF BBO1IJ3ZIW 57BTU4547U 9LYI4RTZ52 VOT5MA71M7 2WZG2G15WX 042SUA2DS9 4O1FFR8ARN 1FH355G8HF Q7Y557L8UZ O12H03B41R PM6E3FG1QK 5928LJ1441 JQ5HI5004M 7X8HL8GRTM QJB9OQO689 700NK45C76 0U790UB32K 9HC15X34LX 89BAT511BD PYO4JR720Y 84ZOM591BB PY0JA16R2G R889N2L976 93963RFO1P 8KDG09A4GO 544F8MEY0Y SVW19ET93C 605T96G8Y5 6607IKD2XX 1BV28146ZR M0G28FH9K1 54UN9R2798 7XW7TB10X9 294L626TT0
RxNorm Concept Unique ID - RxCUI	852327 852323 852656 851739 900948 852719 899596 883495 900843 852712 883416 900116 852817 900753 895356 1299985 897406 903916 852151 852370 851893 852232 900048 852809 883406 900761 900763 900767 1299990 1299992 899668 851869 852181 852342 897335 852224 852630 900676 900994 901002 852741 852057 851877 852749 900111 852584 1014194 852351 900707 852625 852453 900064 899614 899616 899694 852580 900780 901018 852753 851913 900711 852592 900714 852366 852196 852612 889650 899553 900799 901021 900095 900093 900791 852297 851905 1115265 852600 852275 852379 852271 900841 852564 900998 852279 852683 1014758 852165 900773 852169 852284 852672 897982 900734 852263 899648 899579 852572 901014 852422 867300 852177 852305 900134 851747 851743 852499 852494 1013964 897361 899653 899566 899657 901256 900976 901216 900102 900540 900990 852385 852147 852143

Pharmacological Class

Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Increased IgG Production [PE]
Pollen [CS]
Allergens [CS]
Non-Standardized Pollen Allergenic Extract [EPC]

NDC Crossover Matching brand name "Red Maple" or generic name "Red Maple"

NDC	Brand Name	Generic Name
36987-2757	Red Maple	Red Maple
36987-2758	Red Maple	Red Maple
36987-2759	Red Maple	Red Maple
36987-2760	Red Maple	Red Maple
36987-2761	Red Maple	Red Maple
36987-2762	Red Maple	Red Maple
36987-2763	Red Maple	Red Maple
36987-2764	Red Maple	Red Maple
49288-0322	Red Maple	Red Maple
0268-6634	ACER RUBRUM POLLEN	Red Maple
0268-6724	ACER RUBRUM POLLEN	Red Maple

Trademark Results [Red Maple]

Mark Image Registration \| Serial	Company Trademark Application Date
RED MAPLE 88078672 not registered Live/Pending	Henan Xinchi International Trading Co.,Ltd. 2018-08-15
RED MAPLE 88078652 not registered Live/Pending	Henan Xinchi International Trading Co.,Ltd. 2018-08-15
RED MAPLE 88078634 not registered Live/Pending	Henan Xinchi International Trading Co.,Ltd. 2018-08-15
RED MAPLE 85092866 3937547 Live/Registered	Red Maple Technologies, Inc. 2010-07-26
RED MAPLE 77935745 3869570 Live/Registered	RED MAPLE TECHNOLOGIES, INC. 2010-02-15
RED MAPLE 77416274 4007906 Dead/Cancelled	Cranberry Products of Canada Limited 2008-03-07
RED MAPLE 76085134 not registered Dead/Abandoned	Star Business Center, Inc. 2000-07-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.